GlassScriptPhysician profile
Maria Argoud
NPI 1598081820
$13,844.93
in general payments reported to CMS, 2019-2025
42 companies · $2,473 in 2025
The $2,473 reported for 2025 was more than what 93% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,251 · 2022: $2,446 · 2023: $5,247 · 2024: $2,428 · 2025: $2,473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,334 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,700 · Travel and Lodging: $63.48 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,334.22 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,700.00 |
| Travel and Lodging | $63.48 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $3,524.80 | 2021-2025 | V-Go, Afrezza |
| Lilly USA, LLC | $1,480.66 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals LP | $1,390.34 | 2021-2024 | Farxiga, Lokelma |
| Xeris Pharmaceuticals, INC. | $612.96 | 2021-2025 | Gvoke Hypopen, Recorlev |
| Amgen INC. | $606.68 | 2021-2025 | Tepezza, Evenity, Prolia |
| Insulet Corporation | $589.16 | 2021-2025 | Omnipod |
| Abbott Laboratories | $531.73 | 2021-2025 | Freestyle Libre 3, Proclaim |
| Cequr Corporation | $478.40 | 2022-2025 | Cequr Simplicity |
| Zealand Pharma US, INC. | $433.06 | 2021 | |
| Dexcom, INC. | $396.51 | 2021-2025 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $392.21 | 2021-2024 | Wegovy, Rybelsus, Ozempic |
| Sanofi-Aventis U.S. LLC | $374.92 | 2021-2025 | |
| Radius Health, INC. | $351.80 | 2022-2025 | Tymlos |
| Ascensia Diabetes Care US INC. | $301.93 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $277.89 | 2021-2025 | Jardiance, Tradjenta |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Recordati_rare_diseases_inc. | $259.16 | 2023-2025 | Isturisa, Signifor Lar |
| Corcept Therapeutics | $228.10 | 2021-2025 | Korlym |
| Bayer Healthcare Pharmaceuticals INC. | $207.66 | 2021-2025 | |
| Ascendis Pharma Endocrinology INC | $154.66 | 2025 | Yorvipath |
| Horizon Therapeutics Plc | $121.02 | 2022-2023 | Tepezza |
| Almatica Pharma LLC | $112.91 | 2024-2025 | Teriparatide |
| Abbvie INC. | $110.96 | 2022-2025 | |
| Embecta Corp. | $95.46 | 2023-2024 | Bd Nano 2nd Gen Pen Needle |
| Medtronic, INC. | $84.46 | 2021-2025 | Minimed 780g |
| Becton, Dickinson and Company | $81.47 | 2022 | |
| Nevro Corp. | $75.94 | 2022-2024 | Senza |
| Sequel Med Tech, LLC | $62.60 | 2025 | Twiist |
| Kyowa Kirin, INC. | $62.19 | 2023-2025 | |
| Tandem Diabetes Care, INC. | $61.32 | 2021-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Currax Pharmaceuticals LLC | $50.00 | 2023 | Nexletol |
| Rhythm Pharmaceuticals, INC. | $47.70 | 2025 | Imcivree |
| Halozyme INC | $36.02 | 2023 | |
| Beta Bionics, INC. | $34.30 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Pfizer INC. | $34.00 | 2022-2023 | |
| Astellas Pharma US INC | $31.39 | 2025 | Veozah |
| Antares Pharma, INC. | $28.89 | 2023-2024 | Tlando, Xyosted, Nocdurna |
| Alexion Pharmaceuticals, INC. | $25.63 | 2025 | Strensiq |
| Chiesi USA, INC. | $24.32 | 2025 | Myalept |
| Novartis Pharmaceuticals Corporation | $20.75 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $18.04 | 2022 | |
| Amryt Pharma Holdings LTD | $17.44 | 2023 | Mycapssa |
| Amphastar Pharmaceuticals, INC. | $15.49 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Argoud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.